Boston’s Brigham and Women’s Hospital Researchers Selects Vocantas for Clinical Research Study

Vocantas Inc., developer of voice solutions for healthcare, has been selected by Boston’s Brigham and Women’s Hospital (BWH) to help researchers assess the impact of automated telephone follow-up systems on the management of patients on commonly prescribed medications.  Using interactive voice response (IVR) and speech technology, the Vocantas’s CallAssure system enables healthcare providers to evaluate real time patient data.  Study researchers believe that this proactive outreach may facilitate communication between patients and their physicians.

Leading the project is researcher Jennifer Haas, MD, MSPH, at BWH’s Division of General Medicine.  Dr. Haas has studied on the use of technology to improve the quality and safety of patient care, as well as access to care, particularly among the poor and uninsured.

“After three weeks of pilot test calls, the system is functioning well,” says Haas.  “We are looking forward to implementing the technology in our trial to quickly and effectively reach participants and to manage the data efficiently.”

Supporting HL7 standards, the CallAssure system automatically records any symptoms the patient is experiencing in a note, which is then attached to the patient’s electronic medical record.